Literature DB >> 9261615

Assessing the permeability of the gastrointestinal mucosa after oral administration of phenolsulfonphthalein.

Y Toh1, D Korenaga, S Maekawa, T Matsumata, Y Muto, T Ikeda, K Sugimachi.   

Abstract

BACKGROUND/AIMS: In this study, the oral phenolsufonphthalein (PSP) absorption test as a simple and non-invasive method for the assessment of either the extent of the permeability of or damage to the gastrointestinal mucosa was evaluated.
METHODOLOGY: The permeability of the gastrointestinal mucosa of patients with liver cirrhosis and those who underwent gastrointestinal surgery was assessed by the oral administration of 30 mg of PSP and the measurement of its urinary recovery rate.
RESULTS: The urinary PSP excretion in patients with liver cirrhosis (n = 8; 28.8 +/- 6.0%) was significantly higher than that of patients who underwent vascular surgery (n = 8; 10.0 +/- 1.7%) (p < 0.01), which thus suggested an increased permeability of the gastrointestinal mucosa in patients with liver cirrhosis. The urinary PSP excretion rate in patients who underwent a total gastrectomy with Roux-en-Y reconstruction (n = 5) was 17.3 +/- 1.7% which was significantly higher than that observed in the control (p < 0.05), while the same rates in patients who underwent a partial gastrectomy (n = 10) or colectomy (n = 10) were 10.2 +/- 1.8% or 10.6 +/- 0.7%, respectively, which suggested that the intestinal mucosa is damaged by a total resection of the stomach.
CONCLUSIONS: The oral PSP absorption test, which is non-invasive, simple and inexpensive, is thus considered to be useful for assessing the degree of damage to or the permeability of the gastrointestinal mucosa under various conditions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9261615

Source DB:  PubMed          Journal:  Hepatogastroenterology        ISSN: 0172-6390


  6 in total

1.  Small amount of low-residue diet with parenteral nutrition can prevent decreases in intestinal mucosal integrity.

Authors:  K Omura; K Hirano; E Kanehira; K Kaito; M Tamura; S Nishida; K Kawakami; Y Watanabe
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

2.  The role of the gut microbiota in nonalcoholic fatty liver disease.

Authors:  Ahmed Abu-Shanab; Eamonn M M Quigley
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2010-11-02       Impact factor: 46.802

3.  Relevance of plasma malondialdehyde level and severity of portal hypertension in cirrhotic patients.

Authors:  Sheng-Lan Wang; Xin-Yan Zhu; Dong-Wei Zhang; Zhao-Jie Zhang; Heng-Jun Gao; Chang-Qing Yang
Journal:  Int J Clin Exp Med       Date:  2015-07-15

4.  Changes in bowel mucosal permeability and wound healing after neoadjuvant chemotherapy.

Authors:  Masahiro Hada; Kenji Omura; Yasumitsu Hirano; Go Watanabe
Journal:  Oncol Lett       Date:  2010-01-01       Impact factor: 2.967

5.  Increased plasma malondialdehyde in patients with viral cirrhosis and its relationships to plasma nitric oxide, endotoxin, and portal pressure.

Authors:  Kuei-Chuan Lee; Ying-Ying Yang; Ying-Wen Wang; Fa-Yauh Lee; Che-Chuan Loong; Ming-Chih Hou; Han-Chieh Lin; Shou-Dong Lee
Journal:  Dig Dis Sci       Date:  2009-10-14       Impact factor: 3.199

Review 6.  Immune Dysfunction in Cirrhosis.

Authors:  Mohd Talha Noor; Piyush Manoria
Journal:  J Clin Transl Hepatol       Date:  2017-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.